2019 Iron Deficiency Anemia Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

February 2019 | 136 pages | ID: 254F183F5A2EN
VPAResearch

Abstracts

The ongoing clinical trial research report- “2019 Iron Deficiency Anemia Ongoing Clinical Trials Study” analyzes the current scenario of all active Iron Deficiency Anemia trials across the world. The report presents top level analysis of global Iron Deficiency Anemia clinical trials across countries, companies and universities. It is designed to provide clear understanding into the Iron Deficiency Anemia trials landscape to assist users for effective long term strategy formulation to beat competition.

The report covers a key snapshot of ongoing trial count, average enrollment per trial across countries.

It also segments the Iron Deficiency Anemia clinical trials by-

• Region (Asia Pacific, Europe, Middle East Africa and Americas)
• Countries
• Trial Phase
• Current Trial Status (Recruiting, Active, Planned, Active but Completed Recruiting, Not Yet Recruiting etc)
• Type of the trial (Interventional, Observational)
• Sponsor Type (Companies, Universities, Government Bodies etc)
• Enrollment across types, sponsor types, geographies, current status and phases

The report also identifies the potential drug candidates under development for treatment of Iron Deficiency Anemia on the basis of intervention type ongoing Iron Deficiency Anemia trials.

The research work is prepared through extensive and continuous research on Iron Deficiency Anemia trials from over 150 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

REPORT SCOPE AND COVERAGE:

• All major ongoing trials from 2010 to 2019 and planned trials are included in the report scope.
• Drug candidates currently being researched for administering Iron Deficiency Anemia patients are identified
• The report includes panorama of ongoing Iron Deficiency Anemia clinical trials across the globe
• Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
• Companies and universities focusing on Iron Deficiency Anemia clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
• Average Enrollment number, insights into enrollment trends, company wise enrollment are included
• Both interventional and observational studies are analyzed
• News and latest developments for the past one year are presented in the report

Contents

1. TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2. EXECUTIVE SUMMARY

2.1 Iron Deficiency Anemia Ongoing Clinical Trials Overview, 2019
2.2 Premium Insights into Ongoing Clinical Trials
  2.2.1 Ongoing Iron Deficiency Anemia Clinical Trials by Region
  2.2.2 Average Enrollment of Iron Deficiency Anemia Clinical Trials
  2.2.3 Companies participating in Ongoing Trials
  2.2.4 Drugs under Study for Iron Deficiency Anemia Treatment, 2019

3. REGION WISE IRON DEFICIENCY ANEMIA CLINICAL TRIALS

3.1 Asia Pacific Iron Deficiency Anemia Clinical Trials by Country
3.2 Europe Iron Deficiency Anemia Clinical Trials by Country
3.3 North America Iron Deficiency Anemia Clinical Trials by Country
3.4 Middle East and Africa Iron Deficiency Anemia Clinical Trials by Country
3.5 South and Central America Iron Deficiency Anemia Clinical Trials by Country

4. IRON DEFICIENCY ANEMIA CLINICAL TRIAL TRENDS

4.1 Start Year wise Ongoing Iron Deficiency Anemia Clinical Trials
4.2 Phase wise Ongoing Iron Deficiency Anemia Clinical Trials
4.3 Trial Status wise Ongoing Iron Deficiency Anemia Clinical Trials
4.4 Trial Type wise Ongoing Iron Deficiency Anemia Clinical Trials

5. IRON DEFICIENCY ANEMIA AVERAGE ENROLLMENT TRENDS

5.1 Average Enrollment in Iron Deficiency Anemia Trials by Year
5.2 Average Enrollment in Iron Deficiency Anemia Trials by Phase
5.3 Average Enrollment in Iron Deficiency Anemia Trials by Status
5.4 Average Enrollment in Iron Deficiency Anemia Trials by Type of Trial

6. COMPANIES PARTICIPATING IN ONGOING IRON DEFICIENCY ANEMIA CLINICAL TRIALS

6.1 Ongoing Iron Deficiency Anemia Trials by Sponsor Type
6.2 Iron Deficiency Anemia Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS

7.1 Ongoing Iron Deficiency Anemia Trials- Phase
7.2 Ongoing Iron Deficiency Anemia Trials- Phase
7.3 Ongoing Iron Deficiency Anemia Trials- Phase
7.4 Ongoing Iron Deficiency Anemia Trials- Phase

8. APPENDIX

8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List Of Figures

LIST OF FIGURES

Figure 1: Iron Deficiency Anemia Ongoing Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Ongoing Iron Deficiency Anemia Clinical Trials and Enrolment
Figure 5: Europe – Country wise Ongoing Iron Deficiency Anemia Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Ongoing Iron Deficiency Anemia Clinical Trials and Enrolment
Figure 7: North America – Country wise Ongoing Iron Deficiency Anemia Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Ongoing Iron Deficiency Anemia Clinical Trials and Enrolment
Figure 9: Iron Deficiency Anemia Ongoing Clinical Trials by Phase
Figure 10: Iron Deficiency Anemia Ongoing Clinical Trials by Trial Status
Figure 11: Iron Deficiency Anemia Ongoing Clinical Trials by Type
Figure 12: Iron Deficiency Anemia Ongoing Clinical Trials by Sponsor Type
Figure 13: Iron Deficiency Anemia Ongoing Clinical Trials by Leading Sponsors
Figure 14: Iron Deficiency Anemia Average Enrollment by Phase
Figure 15: Iron Deficiency Anemia Average Enrollment by Trial Status
Figure 16: Iron Deficiency Anemia Average Enrollment by Type
Figure 17: Iron Deficiency Anemia- Average Enrolment by Type of Sponsors
Figure 18: Iron Deficiency Anemia- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List Of Tables

LIST OF TABLES

Table 1: Iron Deficiency Anemia Ongoing Clinical Trials Snapshot- 2019
Table 2: Ongoing Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Ongoing Iron Deficiency Anemia Clinical Trials and Enrolment
Table 5: Europe – Country wise Ongoing Iron Deficiency Anemia Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Ongoing Iron Deficiency Anemia Clinical Trials and Enrolment
Table 7: North America – Country wise Ongoing Iron Deficiency Anemia Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Ongoing Iron Deficiency Anemia Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Iron Deficiency Anemia Average Enrollment by Phase
Table 15: Iron Deficiency Anemia Average Enrollment by Trial Status
Table 16: Iron Deficiency Anemia Average Enrollment by Type
Table 17: Iron Deficiency Anemia- Average Enrolment by Type of Sponsors
Table 18: Iron Deficiency Anemia- Enrolment by Leading Sponsors